Magnesium Bisglycinate 250mg Cut Insomnia Severity in a 155-Adult Trial After 4 Weeks
A nationwide German randomized, double-blind, placebo-controlled trial in 155 adults found that 250 mg of elemental magnesium as bisglycinate, taken daily for 4 weeks, produced a significantly greater drop in Insomnia Severity Index (ISI) scores than placebo. Published in Nature and Science of Sleep in 2025, the study clarifies magnesium’s clinical position among sleep supplements.
Design and Results: ISI Change −3.9 vs −2.3
Participants were adults aged 18 to 65 with self-reported poor sleep quality, recruited nationwide across Germany between March and May 2023 via advertising. They were randomly assigned to 250 mg magnesium bisglycinate or a placebo capsule once daily for 4 weeks.
Outcomes:
- Magnesium group: ISI reduction of −3.9 points (95% CI: −5.8 to −2.0)
- Placebo group: ISI reduction of −2.3 points (95% CI: −4.1 to −0.4)
- p = 0.049 (statistically significant)
Both groups improved, with magnesium outperforming placebo by roughly 1.6 points. ISI runs from 0 to 28, and a reduction of 4 or more is generally considered clinically meaningful.
A “Small” But Reliable Effect
Cohen’s d was reported at 0.2, which is a “small effect” in statistical terms. Magnesium bisglycinate is not a dramatic sleep intervention, but it produces a reliable, reproducible improvement over placebo with a strong safety profile.
Low Dietary Magnesium Responders Benefit More
The most interesting finding comes from subgroup analysis. The authors noted “notably greater improvements among participants reporting lower baseline dietary magnesium intake.” This aligns with the general principle that supplements work best in people with actual deficiency, not uniformly across the population.
Adult magnesium RDA is 310-320 mg for women and 400-420 mg for men daily. Per US NHANES data, about 48% of women fall below the RDA. Korean national nutrition surveys also show women’s magnesium intake hovering at 70-80% of recommended levels. Many women are plausibly in the “potential high-responder” group.
Why Bisglycinate
Magnesium supplements differ widely by chelation form.
- Oxide: cheap, high elemental magnesium per dose, poor 4-5% absorption, laxative.
- Citrate: moderate absorption, commonly used for constipation.
- Bisglycinate (glycinate): chelated to two glycine molecules, with higher absorption and minimal GI irritation. Glycine itself functions as an inhibitory neurotransmitter, adding relaxation and sleep benefit.
The study used bisglycinate because the combination of magnesium’s effect plus glycine’s effect is specifically optimized for sleep.
Not a Substitute for Sleep Medication
Magnesium bisglycinate works through a fundamentally different mechanism than prescription sleep drugs (zolpidem, benzodiazepines). Those directly suppress the central nervous system to induce sleep, with dependency and tolerance risks. Magnesium modulates NMDA receptor activity, enhances GABA receptor sensitivity, and supports melatonin synthesis. There is no dependency, and long-term safety is strong.
Practical Guide
When using magnesium bisglycinate for sleep, the common framework is:
- Dose: 200-400 mg elemental magnesium, 30-60 minutes before bed.
- Duration: reassess effect after 4 weeks.
- Dietary check: review magnesium-rich foods. Almonds (1 oz = 80 mg), spinach (1 cup = 150 mg), pumpkin seeds (1 oz = 150 mg), dark chocolate (1 oz = 65 mg).
- Interaction notes: separate from bisphosphonates, and fluoroquinolone or tetracycline antibiotics by 2 hours.
If sleep problems persist for more than 3 months or cause significant daytime impairment, consult a sleep clinic rather than relying on supplementation. Magnesium is a reasonable first-line intervention for transient or mild sleep quality problems, not a replacement for chronic insomnia treatment.